{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:07:43Z","timestamp":1778504863037,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Committee","doi-asserted-by":"publisher","award":["23JCYBJC01060"],"award-info":[{"award-number":["23JCYBJC01060"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Committee","doi-asserted-by":"publisher","award":["23JCYBJC01050"],"award-info":[{"award-number":["23JCYBJC01050"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000131"],"award-info":[{"award-number":["82000131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341213"],"award-info":[{"award-number":["82341213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["T-B-105"],"award-info":[{"award-number":["T-B-105"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2024-I2M-ZH-015"],"award-info":[{"award-number":["2024-I2M-ZH-015"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2024-I2M-TS-023"],"award-info":[{"award-number":["2024-I2M-TS-023"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-041"],"award-info":[{"award-number":["2021-I2M-1-041"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neo.2025.101264","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T07:55:09Z","timestamp":1765958109000},"page":"101264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia"],"prefix":"10.1016","volume":"72","author":[{"given":"Anli","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kejing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6721-1337","authenticated-orcid":false,"given":"Qing","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runxia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sizhou","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingchang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaowei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9437-9151","authenticated-orcid":false,"given":"Jianxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neo.2025.101264_bib0001","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood-2016-01-693879","article-title":"Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia","volume":"128","author":"Metzeler","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.neo.2025.101264_bib0002","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2141.2003.04500.x","article-title":"Flt3 mutations and leukaemia","volume":"122","author":"Kottaridis","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"23","key":"10.1016\/j.neo.2025.101264_bib0003","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1182\/blood-2014-05-578070","article-title":"Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation","volume":"124","author":"Schlenk","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.neo.2025.101264_bib0004","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3324\/haematol.2018.191809","article-title":"Impact of FLT3-ITD length on prognosis of acute myeloid leukemia","volume":"104","author":"Liu","year":"2019","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.neo.2025.101264_bib0005","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2009-03-209999","article-title":"Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome","volume":"114","author":"Kayser","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.neo.2025.101264_bib0006","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/bloodadvances.2023011980","article-title":"Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia","volume":"8","author":"Tarlock","year":"2024","journal-title":"Blood Adv."},{"issue":"9","key":"10.1016\/j.neo.2025.101264_bib0007","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/s41375-022-01650-w","article-title":"Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603\/RATIFY trial","volume":"36","author":"Jahn","year":"2022","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.neo.2025.101264_bib0008","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1182\/blood-2014-04-570929","article-title":"NUP98\/NSD1 and FLT3\/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report","volume":"124","author":"Ostronoff","year":"2014","journal-title":"Blood"},{"issue":"7834","key":"10.1016\/j.neo.2025.101264_bib0009","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","article-title":"Single-cell mutation analysis of clonal evolution in myeloid malignancies","volume":"587","author":"Miles","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neo.2025.101264_bib0010","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","article-title":"Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics","volume":"11","author":"Morita","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.neo.2025.101264_bib0011","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/s41375-024-02211-z","article-title":"Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity","volume":"38","author":"Schwede","year":"2024","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.neo.2025.101264_bib0012","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.exphem.2014.01.010","article-title":"Single cell analysis exposes intratumor heterogeneity and suggests that FLT3-ITD is a late event in leukemogenesis","volume":"42","author":"Shouval","year":"2014","journal-title":"Exp. Hematol."},{"issue":"7382","key":"10.1016\/j.neo.2025.101264_bib0013","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.neo.2025.101264_bib0014","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nm.4410","article-title":"Clonal evolution in leukemia","volume":"23","author":"Ferrando","year":"2017","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.neo.2025.101264_bib0015","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2015-05-646240","article-title":"Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse","volume":"126","author":"Garg","year":"2015","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.neo.2025.101264_bib0016","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood.2020007626","article-title":"Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin","volume":"137","author":"Schmalbrock","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.neo.2025.101264_bib0017","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2006-05-023804","article-title":"Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways","volume":"109","author":"Piloto","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.neo.2025.101264_bib0018","article-title":"Risk stratification in the clinical application of minimal residual disease assessment in acute myeloid leukemia","author":"Zhang","year":"2024","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.neo.2025.101264_bib0019","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41408-024-01144-1","article-title":"Multiomic analysis identifies a high-risk subgroup that predicts poor prognosis in t(8;21) acute myeloid leukemia","volume":"14","author":"Liu","year":"2024","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.neo.2025.101264_bib0020","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1038\/s41467-021-27472-5","article-title":"Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia","volume":"12","author":"Benard","year":"2021","journal-title":"Nat. Commun."},{"issue":"Pt 2","key":"10.1016\/j.neo.2025.101264_bib0021","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1348\/0007110042307195","article-title":"Bradley-Terry-Luce models to incorporate within-pair order effects: representation and uniqueness theorems","volume":"57","author":"Augustin","year":"2004","journal-title":"Br. J. Math. Stat. Psychol."},{"issue":"1","key":"10.1016\/j.neo.2025.101264_bib0022","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1186\/s12864-016-3195-z","article-title":"Visualizing tumor evolution with the fishplot package for R","volume":"17","author":"Miller","year":"2016","journal-title":"BMC Genom."},{"issue":"1","key":"10.1016\/j.neo.2025.101264_bib0023","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/annonc\/mdu479","article-title":"Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data","volume":"26","author":"Favero","year":"2015","journal-title":"Ann. Oncol."},{"issue":"14","key":"10.1016\/j.neo.2025.101264_bib0024","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood-2009-10-201848","article-title":"Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies","volume":"115","author":"O'Keefe","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.neo.2025.101264_bib0025","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/gcc.22210","article-title":"Analysis for loss of heterozygosity on chromosome arm 13q by STR analysis or SNP sequencing can replace analysis of FLT3-ITD to detect patients with prognostically adverse AML","volume":"53","author":"Schnittger","year":"2014","journal-title":"Gene. Chromosome. Cancer"},{"issue":"4","key":"10.1016\/j.neo.2025.101264_bib0026","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.neo.2025.101264_bib0027","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.neo.2025.101264_bib51","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.neo.2025.101264_bib0028","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/2643-3230.BCD-23-0195","article-title":"IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation","volume":"5","author":"Landberg","year":"2023","journal-title":"Blood Cancer Discov."},{"issue":"6","key":"10.1016\/j.neo.2025.101264_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114260","article-title":"Immunotherapeutic targeting of surfaceome heterogeneity in AML","volume":"43","author":"Bordeleau","year":"2024","journal-title":"Cell Rep."},{"issue":"23","key":"10.1016\/j.neo.2025.101264_bib0030","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124928","article-title":"Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry","volume":"3","author":"Oetjen","year":"2018","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.neo.2025.101264_bib0031","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ccell.2024.10.009","article-title":"In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy","volume":"42","author":"Bowman","year":"2024","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.neo.2025.101264_bib0032","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.3390\/cancers12102874","article-title":"DNA repair expression profiling to identify high-risk cytogenetically normal acute myeloid leukemia and define new therapeutic targets","volume":"12","author":"Gabellier","year":"2020","journal-title":"Cancer. (Basel)"},{"issue":"11","key":"10.1016\/j.neo.2025.101264_bib0033","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1182\/blood.2019003339","article-title":"Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis","volume":"135","author":"Bezerra","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.neo.2025.101264_bib0034","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1182\/blood.2018862383","article-title":"Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML","volume":"134","author":"Garg","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.neo.2025.101264_bib0035","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.neo.2025.101264_bib0036","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3324\/haematol.2019.243410","volume":"105","author":"Bazarbachi","year":"2020","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.neo.2025.101264_bib0037","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.stem.2025.01.012","article-title":"Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemic driver mutations","volume":"32","author":"Singh","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"21","key":"10.1016\/j.neo.2025.101264_bib0038","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1158\/1078-0432.CCR-19-0725","article-title":"Genetic characterization and prognostic relevance of acquired uniparental disomies in cytogenetically normal acute myeloid leukemia","volume":"25","author":"Walker","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.neo.2025.101264_bib0039","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/jha2.390","article-title":"Single cell proteogenomic sequencing identifies a relapse-fated AML subclone carrying FLT3-ITD with CN-LOH at chr13q","volume":"3","author":"Kim","year":"2022","journal-title":"EJHaem."},{"issue":"5","key":"10.1016\/j.neo.2025.101264_bib0040","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1038\/bcj.2014.27","article-title":"Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3\/ITD AML","volume":"4","author":"Stirewalt","year":"2014","journal-title":"Blood Cancer J."},{"issue":"20","key":"10.1016\/j.neo.2025.101264_bib0041","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/bloodadvances.2018020305","article-title":"Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia","volume":"2","author":"Sakaguchi","year":"2018","journal-title":"Blood Adv."},{"issue":"7","key":"10.1016\/j.neo.2025.101264_bib0042","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1158\/0008-5472.CAN-16-1678","article-title":"FLT3 and JAK2 mutations in acute myeloid leukemia promote interchromosomal homologous recombination and the potential for copy neutral loss of heterozygosity","volume":"77","author":"Gaymes","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2025.101264_bib0043","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood-2018-02-834895","article-title":"Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors","volume":"132","author":"Maifrede","year":"2018","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.neo.2025.101264_bib0044","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1158\/0008-5472.CAN-20-3761","article-title":"TET2 and DNMT3A mutations exert divergent effects on DNA repair and sensitivity of leukemia cells to PARP inhibitors","volume":"81","author":"Maifrede","year":"2021","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.neo.2025.101264_bib0045","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1172\/JCI129126","article-title":"Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia","volume":"130","author":"Klossowski","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.neo.2025.101264_bib0046","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13148-019-0723-0","article-title":"Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair","volume":"11","author":"Ye","year":"2019","journal-title":"Clin. Epigenet."},{"issue":"Supplement 1","key":"10.1016\/j.neo.2025.101264_bib0047","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1182\/blood-2025-1710","article-title":"DNMT3A, NPM1, and FLT3-ITD triple-mutated AML has a favorable prognosis in the era of FLT3 inhibitors","volume":"146","author":"Mo","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.neo.2025.101264_bib0049","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2025.288553","article-title":"Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor","author":"Short","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.neo.2025.101264_bib0050","article-title":"RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance","author":"Kennedy","year":"2025","journal-title":"bioRxiv"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:06:22Z","timestamp":1769832382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"alternative-id":["S1476558625001435"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101264","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101264"}}